Sonoma Pharmaceuticals (SNOA) Other Operating Expenses (2015 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Other Operating Expenses of -$271000.0 in Q4 2025, up 31.22% quarter-over-quarter from -$394000.0 in Q3 2025, and down 341.96% on a YoY basis from $112000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Other Operating Expenses (2015 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Other Operating Expenses history runs 11 years deep, the most recent figure standing at -$271000.0 for Q4 2025.
- In Q4 2025, Other Operating Expenses fell 341.96% year-over-year to -$271000.0; the TTM figure through Dec 2025 stood at -$684000.0 (down 194.34% YoY), while the FY2025 annual figure was $803000.0, up 343.33% from the prior year.
- Other Operating Expenses was -$271000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from -$394000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $387000.0 in Q3 2024 to a low of -$731000.0 in Q1 2021.
- Historically, Other Operating Expenses has averaged -$119631.6 across 5 years, with a median of -$90000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses jumped 530.0% in 2024, then slumped 341.96% in 2025.
- A 5-year view of Other Operating Expenses shows it stood at $150000.0 in 2021, then sank by 147.33% to -$71000.0 in 2022, then decreased by 11.27% to -$79000.0 in 2023, then soared by 241.77% to $112000.0 in 2024, then plunged by 341.96% to -$271000.0 in 2025.
- The last three Other Operating Expenses figures came in at -$271000.0 (Q4 2025), -$394000.0 (Q3 2025), and -$147000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -271,000.00 |
| Sep 30, 2025 | -394,000.00 |
| Jun 30, 2025 | -147,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Jun 30, 2023 | -211,000.00 |
| Mar 31, 2023 | -292,000.00 |
| Dec 31, 2022 | -71,000.00 |
| Sep 30, 2022 | -186,000.00 |
| Jun 30, 2022 | -67,000.00 |
| Mar 31, 2022 | -544,000.00 |
| Sep 30, 2021 | 150,000.00 |
| Jun 30, 2021 | -193,000.00 |
| Mar 31, 2021 | -731,000.00 |
| Dec 31, 2020 | 4,000.00 |